Reduced metastatic behavior: EGCG attenuated tumor spread in vitro, evidenced by impaired migration/invasion of colon cancer cells. Inhibition of the HGF/c-Met axis by EGCG suggests a specific molecular target through which EGCG can prevent metastasis. This highlights EGCG’s potential to curb metastatic progression in solid tumors. Here, MET is linked to malignant colon neoplasm.